Gossypol Acetate
Phase 2
Gossypol Acetate is one of 13 therapeutic programs targeting Advanced Colorectal Cancer. It is currently in Phase 2.
1
Indications
1
Total Trials
1
Active Trials
12
Competitors
Pipeline
Status by Indication[2][1]
Indication
Competition
Competitive Landscape
12 competitors in Advanced Colorectal Cancer
#DrugCompanyPhaseTrials
1Erbitux
IImclone
Phase 3
Ayvakit Sprinkle
MMemorial Sloan Kettering Cancer Center
Phase 2
Tyvyt
Innovent Biologics (Suzhou) Co. Ltd.Phase 2
MRTX849
MMirati Therapeutics Inc.
Phase 3
Defactinib
VVerastem, Inc.
Phase 2
Eloxatin
TevaPreclinical
Avastin
RochePreclinical
Xeloda
EEngelhard Arzneimittel GmbH & Co.KG
Preclinical
5-Fluorouracil
Merck & Co.Preclinical
Gossypol Acetate
PPeking University People's Hospital
Phase 2
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Expected Milestones
Clinical
Trials by Indication[1]
Advanced Colorectal Cancer1 trial
Sources
References
- [1]
- [2]Open Targets Platform — Drug–disease associations for Gossypol Acetate. EMBL-EBI & Wellcome Sanger Institute.
- [3]
Details
Drug Info
Quick Facts
- Highest Phase
- Phase 2[1]